Impact of abdominal fat and insulin resistance on arterial hypertension in non-obese women;Impacto da gordura abdominal e resistência à insulina na hipertensão arterial em mulheres não-obesas

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 53, Issue 3, 2009, Pages 340-343

  Silva, Eliana A ^a   Flexa, Fernando ^a   Zanella, Maria Teresa ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Hypertension; Insulin resistance; Subcutaneous fat; Visceral fat

Indexed keywords

EID: 68249144583     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/s0004-27302009000300007     Document Type: Article

References (19)

1. Third Report of The National Cholesterol Education program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143-421.
2. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the Metabolic Syndrome. Endocr Rev. 2000;21(6):697-738.
3. Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, et al. Relation of body fat distribution to metabolic complications of obesity. Clin Endocrinol Metab. 1982;54(2):254-60.
4. Ferrannini E, Holffner SM, Mitchell BD, Stern MP. Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia. 1991;34(6):416-22.
5. Carr DB, Utzschneider KM, Hull RL, Kodama K, Retzlaff BM, Brunzell JD, et al. Intra-abdominal fat is a major determinant of the National Cholesterol Education Program Adult Treatment panel III. Criteria for the Metabolic Syndrome. Diabetes. 2004;53(8):2087-94.
6. Hayashi T, Boyko EJ, Leonetti DL, McNeely MJ, Newell-Morris L, Kahn SE, et al. Visceral adiposity is an independent predictor of incident hypertension in Japanese Americans. Ann Intern Med. 2004;140(12):992-1000.
7. Anderson EA, Mark AL. The vasodilatador action of insulin. Implications for the insulin hypotesis of hypertension. Hypertension. 1993;21(2):136-41.
8. Faria AN, Ribeiro-Filho FF, Ferreira SRG, Zanella MT. Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obesity Research. 2002;10(12):1203-6.
9. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988;37(12):1595-607.
10. Sironi AM, Gastaldelli A, Mari A, Ciociaro D, Positano V, Buzzigoli E, et al. Visceral fat in hypertension. Influence on insulin resistance and β-cell function. Hypertension. 2004;44(2):127-33.
11. Van Harmelen, Reynisdottir S, Eriksson P, Thörne A, Hoffstedt J, Lönnqvist F, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998;47(6):913-7.
12. Shek EW, Brands MW, Hall JE. Chronic leptin infusion increases arterial pressure. Hypertension. 1998;31(1 Pt 2):409-14.
13. Dagogo-Jack S, Fanelli C, Paramore D, Brothers J, Landt M. Plasma leptin and insulin relationships in the obese and non-obese humans. Diabetes. 1996;45(5):695-8.
14. Hall JE, Zappe D, Kassab S. Mechanisms of obesity induced hypertension. News Physiol Sci. 1996;11:255-61.
15. Belfiore F, Ianello S, Volpicelli G. Insulin sensitivity of blood glucose versus insulin sensitivity of blood free fatty acids in normal, obese and obese-diabetic subjects. Metabolism. 1998;63:134-41.
16. Kelley DE, Thaete L, Trost F, Goodpaster BH. Subdivisions of subcutaneous abdominal adipose tissue and insulin resistance. Am J Physiol Endocrinol Metab. 2000;278(5):941-8.
17. Cefalu WT, Wang ZQ, Werbel S, Bel-Farrow AD, Terry JA, Wang ZQ, et al. Contribution of visceral fat mass to the insulin resistance of aging. Metabolism. 1995;44(7):954-9.
18. Fujioka S, Matsuzawa Y, Tarui S, et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism. 1987;36(1):54-7.
19. Lamon-Fava S, Wilson PWF, Schaefer EJ. Impact of body mass index on coronary heart disease risk factors in men and women. The Framingham Offspring Study. Arterioscl Thromb Vasc Biol.1996; 16(12):1509-15.